Pressure from Brain Tumors Triggers Self-Destruct Mechanism in Neurons, Study Finds

Brain tumors may damage surrounding tissue in a more insidious way than previously understood. New research from the University of Notre Dame shows that chronic pressure from an expanding tumor does not simply crush nearby neurons. It activates an internal self-destruction program that pushes those cells toward death. 

Neurons form the backbone of thought, movement and sensation. When they die, the brain cannot easily replace them. That loss often leads to cognitive decline, motor impairment and sensory deficits seen in patients with aggressive brain cancers and traumatic injuries. 

An interdisciplinary team at the University of Notre Dame set out to examine how mechanical compression alone affects healthy brain cells. Meenal Datta, a professor of aerospace and mechanical engineering and co-lead author of the study, said most cancer research focuses on eliminating tumor cells while overlooking what the growing mass does to the organ around it. She said the physical forces generated as a tumor expands appear to play a central role in damaging the brain. 

To isolate that effect, the researchers built lab-grown neural networks using induced pluripotent stem cells, which can be reprogrammed from adult blood or skin samples and turned into neurons. They applied controlled pressure to mimic the slow squeeze of a tumor such as glioblastoma. They also tested the findings in preclinical models. 

The test results were extremely encouraging, with even neurons that survived the initial compression showing signs that a programmed cell death pathway had been switched on. Christopher Patzke, a biological sciences professor and co-lead author, said many of the surviving cells were already primed to dismantle themselves. The team wanted to identify which molecular signals were driving that process and whether it could be stopped. 

Genetic analysis revealed elevated activity in stress-related pathways, including molecules associated with HIF-1 signaling and activation of the AP-1 gene. Those changes are linked to inflammation and cellular stress responses. The same patterns were observed in data from glioblastoma patients, suggesting the lab findings reflect what happens in human brains under sustained pressure. 

The implications extend beyond cancer to potentially addressing other conditions. Because the study focused on the physics of compression rather than a specific disease, the researchers believe similar mechanisms could be triggered in conditions such as traumatic brain injury or hydrocephalus, where abnormal pressure builds inside the skull. 

Datta described the work as an effort to bring mechanics into the center of brain disease research, arguing that physical forces are often overlooked despite shaping how cells behave. Patzke added that understanding why neurons are so vulnerable under compression is essential if scientists hope to prevent permanent neurological damage. 

The findings, published in the journal Proceedings of the National Academy of Sciences, point toward new drug targets aimed at blocking the self-destruct signals before widespread neuron loss occurs. For patients facing brain tumors, that approach could one day mean preserving function even when a cure remains out of reach. 

With advancements being recorded by companies like CNS Pharmaceuticals Inc. (NASDAQ: CNSP) in their efforts to develop novel drugs targeting different brain cancers, the progress being made in understanding the mechanics of how tumor progression impacts healthy brain tissue is a big step forward as it could lead to a more holistic approach to treating brain tumors. 

About TinyGems

TinyGems is a specialized communications platform with a focus on innovative small-cap and mid-cap companies with bright futures and huge potential. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, TinyGems is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, TinyGems brings its clients unparalleled recognition and brand awareness. TinyGems is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from TinyGems, text “Gems” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.TinyGems.com

Please see full terms of use and disclaimers on the TinyGems website applicable to all content provided by TinyGems, wherever published or re-published: https://www.TinyGems.com/Disclaimer

TinyGems
Austin, Texas
www.TinyGems.com
512.354.7000 Office
Editor@TinyGems.com

TinyGems is powered by IBN